IBEX Pharmaceuticals Inc Company
IBEX markets a line of recombinant high-purity proprietary enzymes from Flavobacterium heparinum.
Funding Status:
IPO
Headquarters:
Canada
Technology:
Others
Estimated Revenue:
$1M to $10M
Industry:
Telemedicine